JESFC 2023

Traitement, prise en charge

Publié le jeudi 12 janvier 2023

Modérateur(s) :

Corentin Bourg , François Picard

Orateur(s) :

Messaouda Djouhri , Laetitia Pourtau , Nicolas Chapet , Jeremy Marot , Hinda Allaoui , Hanae Charif , Nabila Taleb Bendiab , Liane Bourcier , Chris Nadège Nganou-Gnindjio , Guillaume Coutance , Tatiana Hertzog

Dans la session

Messaouda Djouhri Impact of therapeutic optimization and prevalence of reverse remodeling in heart failure with reduced ejection fraction. About a series of 252 pati...
Laetitia Pourtau Prevalence, management and outcomes of haemorrhagic events in left ventricular assist device recipients
Jeremy Marot Description of the care pathway for patients hospitalized for acute heart failure (AHF)
Nabila Taleb Bendiab Impact of SGLT2 inhibitors on the evolution of echocardiographic parameters of patients with chronic heart failure
Liane Bourcier Effects of COLchicine on inflammation, myocardial damage and microvascular dysfunction in heart failure with Preserved Ejection Fraction – The COLp...
Guillaume Coutance Application of the new cardiac allograft allocation scheme in clinical practice. Insights from a high-volume heart transplantation center
Tatiana Hertzog Prevalence of early and late left ventricular reverse remodeling in dilated cardiomyopathy under optimal medical therapy

Partager l'article :